NIFTY 50 23344.75 ▲ (0.61%)
NIFTY NEXT 50 65106.15 ▲ (0.08%)
NIFTY 100 24048.8 ▲ (0.51%)
NIFTY MIDCAP 100 55106.2 ▲ (0.91%)
NIFTY SMALLCAP 100 17864.65 ▲ (1.09%)
NIFTY SMALLCAP 250 16841.4 ▲ (0.84%)
NIFTY MIDCAP SELECT 12356.5 ▲ (0.87%)
NIFTY TOTAL MARKET 12304.6 ▲ (0.6%)
NIFTY BANK 49350.8 ▲ (1.67%)
SENSEX 77073.44 ▲ (0.59%)
BSE BANKEX 56036.23 ▲ (2.03%)

Arunjyoti Bio Ventures Reports Q1: Revenue Up by 260.81% Year-on-Year

Image is loading

Highlights

  • The presented financial data is Standalone to provide a comprehensive overview of the company performance.
  • Sales over the Year and quarter: The company experienced a substantial growth of 260.81 % in the past year, substantial increase in net sales/revenue by 16.07 %.
  • Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 809.09 %. Marginal increase in other income during this quarter, up by 338.1%.
  • Profit over the Year and quarter: Significant improvement in profitability for Arunjyoti Bio Ventures Limited . Notable increase of 3834.88 % in net profit Year to Year, Arunjyoti Bio Ventures Limited ‘s profitability increased by 34.18 % in this quarter.
  • EPS over the Year and quarter: EPS increased by 428.57 % Year to Year. EPS decreased by -81.77 % in previous quarter. Analysis needed for shareholder value.

The comprehensive analytics outlining the performance and outlook of Arunjyoti Bio Ventures Limited ‘s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 2.799 Cr Rs. 8.701 Cr Rs. 10.099 Cr + 16.07 % + 260.81 %
Expenses Rs. 2.74 Cr Rs. 7.46 Cr Rs. 6.56 Cr -12.06 % + 139.42 %
Operating Profit Rs. 0.06 Cr Rs. 1.24 Cr Rs. 3.54 Cr + 185.48 % + 5800 %
OPM % 2.14 % 14.25 % 35.05 % + 20.8 % + 32.91 %
Other Income Rs. 0.011 Cr Rs. -0.042 Cr Rs. 0.1 Cr + 338.1 % + 809.09 %
Interest Rs. 0.01 Cr Rs. 0.8 Cr Rs. 0.67 Cr -16.25 % + 6600 %
Depreciation Rs. 0 Cr Rs. 0.81 Cr Rs. 0.72 Cr -11.11 % 0 %
Profit before tax Rs. 0.06 Cr Rs. -0.41 Cr Rs. 2.25 Cr + 648.78 % + 3650 %
Tax % 24.14 % -408.31 % 24.83 % + 433.14 % + 0.69 %
Net Profit Rs. 0.04 Cr Rs. 1.26 Cr Rs. 1.69 Cr + 34.13 % + 4125 %
EPS in Rs Rs. 0.21 Rs. 6.09 Rs. 1.11 -81.77 % + 428.57 %


Today, we’re looking at Arunjyoti Bio Ventures Limited ‘s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 260.81 %. However, it did see a marginal increase of 16.07 % from the previous quarter. Expenses decreased slightly by -12.06 % quarter-on-quarter, aligning with the annual rise of 139.42 %. Operating profit, while up 5800 % compared to last year, faced a quarter-on-quarter increase of 185.48 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 32.91 %, but an expansion of 20.8 % sequentially. Other income rose by 338.1 % compared to the last quarter, despite an annual growth of 809.09 %. Interest expenses dropped significantly by -16.25 % from the previous quarter, yet the year-over-year increase remains at a moderate 6600 %. Depreciation costs fell by -11.11 % quarter-on-quarter, Profit before tax grew annually by 3650 % but saw an increase from the preceding quarter by 648.78 %.
Tax expenses as a percentage of profits increased slightly by 0.69 % compared to last year, with a more notable quarter-on-quarter increase of 433.14 %. Net profit rose by 4125 % year-on-year but experienced a 34.13 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 428.57 % but a quarterly fall of -81.77 %. In summary, Arunjyoti Bio Ventures Limited ‘s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 2.799 Cr Rs. 8.701 Cr Rs. 10.099 Cr + 16.07 % + 260.81 %
Expenses Rs. 2.74 Cr Rs. 7.46 Cr Rs. 6.56 Cr -12.06 % + 139.42 %
Operating Profit Rs. 0.06 Cr Rs. 1.24 Cr Rs. 3.54 Cr + 185.48 % + 5800 %
Net Profit Rs. 0.04 Cr Rs. 1.26 Cr Rs. 1.69 Cr + 34.13 % + 4125 %
EPS in Rs Rs. 0.21 Rs. 6.09 Rs. 1.11 -81.77 % + 428.57 %


In reviewing Arunjyoti Bio Ventures Limited ‘s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 260.81 % year-on-year growth, however, there was a minor increase of 16.07 % from the previous quarter. Expenses rose by 139.42 % compared to the previous year, with a decrease of -12.06 % quarter-on-quarter. Operating Profit surged by 5800 % annually, and saw a 185.48 % increase from the last quarter.
Net Profit showed yearly increase of 4125 %, and experienced a 34.13 % increase from the previous quarter. Earnings Per Share (EPS) rose by 428.57 % annually, however dipped by -81.77 % compared to the last quarter. In essence, while Arunjyoti Bio Ventures Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.

[my_shortcode1]

Join our telegram for more updates

Stay Updated with Our YouTube Videos

Related Post